IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Basic tumor immunology

Original research

IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors

Online download statistics by month:

Online download statistics by month: April 2021 to March 2024

	Abstract	Full	Pdf
Apr 2021	760	760	277
May 2021	535	536	135
Jun 2021	215	215	57
Jul 2021	131	131	32
Aug 2021	150	150	30
Sep 2021	107	107	36
Oct 2021	132	132	58
Nov 2021	163	163	53
Dec 2021	122	124	39
Jan 2022	92	102	39
Feb 2022	77	79	31
Mar 2022	114	125	48
Apr 2022	131	159	48
May 2022	105	119	54
Jun 2022	114	131	53
Jul 2022	104	112	44
Aug 2022	94	104	42
Sep 2022	92	100	72
Oct 2022	94	98	31
Nov 2022	108	115	61
Dec 2022	85	86	47
Jan 2023	110	111	56
Feb 2023	147	157	57
Mar 2023	114	117	43
Apr 2023	123	129	40
May 2023	97	98	33
Jun 2023	91	93	45
Jul 2023	55	56	25
Aug 2023	65	72	24
Sep 2023	45	46	29
Oct 2023	93	94	45
Nov 2023	142	144	53
Dec 2023	174	176	48
Jan 2024	50	51	29
Feb 2024	127	132	50
Mar 2024	175	178	103
Total	5133	5302	1967